- Home
- Publications
- Publication Search
- Publication Details
Title
Nanozyme-Based Enhanced Cancer Immunotherapy
Authors
Keywords
-
Journal
Tissue Engineering and Regenerative Medicine
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-31
DOI
10.1007/s13770-022-00430-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Three-in-one ZIFs-Derived CuCo(O)/GOx@PCNs Hybrid Cascade Nanozyme for Immunotherapy/Enhanced Starvation/Photothermal Therapy
- (2021) Qi Wang et al. ACS Applied Materials & Interfaces
- High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis–Ferroptosis Synergistic Tumor Therapy
- (2021) Xiangqin Meng et al. ACS Nano
- Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
- (2021) Nada S. Aboelella et al. Cancers
- Remodeling of Tumor Microenvironment by Tumor‐Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy
- (2021) Lipeng Zhu et al. Small
- Role of heterogeneous regulatory T cells in the tumor microenvironment
- (2020) Ting Wei et al. PHARMACOLOGICAL RESEARCH
- Self-Assembled Multiple-Enzyme Composites for Enhanced Synergistic Cancer Starving–Catalytic Therapy
- (2020) Huihui Wang et al. ACS Applied Materials & Interfaces
- Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold
- (2020) Thanh Loc Nguyen et al. BIOMATERIALS
- Hypoxia-Driven Immune Escape in the Tumor Microenvironment
- (2020) Alyssa Vito et al. Cells
- Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine
- (2020) Jun Yup Lee et al. ACS Applied Materials & Interfaces
- Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy
- (2020) Bolong Xu et al. ADVANCED MATERIALS
- Enhanced Cancer DNA Vaccine via Direct Transfection to Host Dendritic Cells Recruited in Injectable Scaffolds
- (2020) Thanh Loc Nguyen et al. ACS Nano
- Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer
- (2020) Matthew D. Kerr et al. Expert Opinion on Drug Discovery
- Targeting tumor‑associated macrophages in the tumor microenvironment (Review)
- (2020) Kaiwen Zhou et al. Oncology Letters
- Nanozyme‐Initiated In Situ Cascade Reactions for Self‐Amplified Biocatalytic Immunotherapy
- (2020) Yajie Zhao et al. ADVANCED MATERIALS
- Na2S2O8 Nanoparticles Trigger Antitumor Immunotherapy through Reactive Oxygen Species Storm and Surge of Tumor Osmolarity
- (2020) Yang Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
- (2019) Jun Zhao et al. Nature Communications
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Photosensitizers for Photodynamic Therapy
- (2019) Minhuan Lan et al. Advanced Healthcare Materials
- Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy
- (2019) Hongwei Chen et al. Nanomedicine
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
- (2018) Ruijing Liang et al. BIOMATERIALS
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation
- (2018) Jia Yao et al. Chemical Science
- Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
- (2018) Fei Tang et al. Cell and Bioscience
- Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy
- (2018) Bong Geun Cha et al. ACS Central Science
- Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
- (2017) Somala Mohammed et al. MOLECULAR THERAPY
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
- (2016) M. V. Maus et al. CLINICAL CANCER RESEARCH
- Targeting regulatory T cells in tumors
- (2016) Chang Liu et al. FEBS Journal
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acidic tumor microenvironment in human melanoma
- (2016) Ines Böhme et al. Pigment Cell & Melanoma Research
- Myeloid-derived suppressor cells and tumor escape from immune surveillance
- (2016) Viktor Umansky et al. Seminars in Immunopathology
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Plasmon-Mediated Generation of Reactive Oxygen Species from Near-Infrared Light Excited Gold Nanocages for Photodynamic Therapy in Vitro
- (2014) Liang Gao et al. ACS Nano
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
- (2014) M. V. Sitkovsky et al. Cancer Immunology Research
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T Cells: Major Players in the Tumor Microenvironment
- (2009) Marc Beyer et al. CURRENT PHARMACEUTICAL DESIGN
- Catalase mimics of a manganese(II) complex: The effect of axial ligands and pH
- (2007) József Kaizer et al. JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation